ECOR (electroCore) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ECOR electroCore Inc ECOR
76 GF Score
Price $9.73
GF Value $8.64
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is electroCore Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ECOR
76GF Score
electroCore Inc ECOR
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is electroCore (ECOR) Overvalued in 2026?

Based on GuruFocus' analysis, electroCore stock appears to be overvalued. The current stock price of $9.73 is trading 12.6% above its estimated GF Value™ of $8.64. GuruFocus considers electroCore to be Modestly Overvalued.

Key valuation signals for ECOR:

  • Short Ratio:
  • GF Value™: $8.64 vs. price of $9.73 (12.6% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the ECOR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


electroCore Business Description

Other Exchanges 43E0:Germany
Address 200 Forge Way, Suite 205, Rockaway, NJ, USA, 07866
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
76GF Score

Get the complete analysis for ECOR

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.73
Price
$8.64
GF Value